ÌÇÐÄvlog

This open-label extension study assesses the safety and efficacy of dupilumab treatment for up to 5 years in adults with moderate to severe atopic dermatitis.

This secondary analysis of 2 clinical trials examines the validity and fit-for-purpose of the Worst Itch Numeric Scale for assessing patient-reported outcomes of pruritus following treatment for prurigo nodularis.

This cohort study aims to define the spectrum of cutaneous manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome and the association of these findings with clinical, genetic, and histological features.

This meta-analysis examines the association between clinical characteristics and the clinical response among patients with psoriasis treated with biologics.

This cohort study investigates nail abnormality prevalence among patients with (BRCA1-associated protein) BAP1 tumor predisposition syndrome.

This meta-analysis provides a detailed global prevalence estimate of seborrheic dermatitis, examining variations across different sociodemographic factors and settings.

This randomized clinical trial evaluates the efficacy and safety of cendakimab compared with placebo in patients with moderate to severe atopic dermatitis.